EXCLUSIVE SUBLICENSE AGREEMENTExclusive Sublicense Agreement • November 19th, 2008 • Biotime Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledNovember 19th, 2008 Company Industry JurisdictionThis Exclusive Sublicense Agreement (“Agreement”) is made and entered into as of the 15th day of August, 2008 (the “Effective Date”), by and between Advanced Cell Technology, Inc., a Delaware corporation with offices located at 11100 Santa Monica Blvd, Suite 850, Los Angeles, CA 90025 (“ACT”), Embryome Sciences, Inc., a California corporation (“ES”), with offices located at 1301 Harbor Bay Parkway, Suite 100, Alameda, California 94502. ACT and ES are sometimes hereinafter referred to as the “Parties”.
FOURTH AMENDMENT OF SECURITY AGREEMENTFourth Amendment of Security Agreement • November 19th, 2008 • Biotime Inc • Biological products, (no disgnostic substances)
Contract Type FiledNovember 19th, 2008 Company IndustryThis Fourth Amendment of Security Agreement (“Fourth Amendment”) is made as of November 14, 2008 by BioTime, Inc., as the “Debtor,” in favor and for the benefit of each “Secured Party,” and amends that certain Third Amended and Restated Security Agreement, March 31, 2008.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 19th, 2008 • Biotime Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledNovember 19th, 2008 Company Industry JurisdictionThis Exclusive License Agreement (“Agreement”) is made and entered into as of the 15th day of August, 2008 (the “Effective Date”), by and between Advanced Cell Technology, Inc., a Delaware corporation with offices located at 11100 Santa Monica Blvd, Suite 850, Los Angeles, CA 90025 (“ACT”), Embryome Sciences, Inc., a California corporation (“LICENSEE”), with offices located at 1301 Harbor Bay Parkway, Suite 100, Alameda, California 94502. ACT and LICENSEE are sometimes hereinafter referred to as the “Parties.”
FOURTH AMENDMENT OF REVOLVING LINE OF CREDIT AGREEMENTLine of Credit Agreement • November 19th, 2008 • Biotime Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledNovember 19th, 2008 Company Industry JurisdictionThis Fourth Amendment of Revolving Line of Credit Agreement is made and entered into as of November 14, 2008, by and among each of the persons who have executed this Agreement as a Lender (each a “Lender,” and collectively “Lenders”), and BioTime, Inc., a California corporation (“Borrower”), and amends that certain Third Amended and Restated Credit Agreement dated March 31, 2008. The Third Amended and Restated Credit Agreement, dated March 31, 2008, as amended by this Fourth Amendment of Revolving Credit Agreement is referred to as the “Credit Agreement”.